Advertisement
Advertisement
KMTS
Kestra Medical Technologies, Ltd. Common Stock
21.83
USDSponsored
+0.78
+3.71%
May 11, 15:59 UTC -4
Closed
After-Market
21.86
+0.03
+0.11%
KMTS Earnings Reports
Positive Surprise Ratio
KMTS beat 1 of 4 last estimates.
25%
Next Report
Date of Next Report
Jul 16, 2026
Estimate for Q4 26 (Revenue/ EPS)
$27.01M
/-$0.60
Implied change from Q3 26 (Revenue/ EPS)
+10.01%
/-1.64%
Implied change from Q4 25 (Revenue/ EPS)
+56.73%
/-72.85%
Kestra Medical Technologies, Ltd. Common Stock earnings per share and revenue
On Mar 17, 2026, KMTS reported earnings of -0.61 USD per share (EPS) for Q3 26, missing the estimate of -0.60 USD, resulting in a -0.39% surprise. Revenue reached 24.55 million, compared to an expected 23.32 million, with a 5.29% difference. The market reacted with a -7.38% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of -0.60 USD, with revenue projected to reach 27.01 million USD, implying an decrease of -1.64% EPS, and increase of 10.01% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
BioLife Solutions Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.02
Actual
$0.04
Surprise
+96.08%
CeriBell, Inc. Common Stock
Report Date
May 11, 2026 For Q1 26
Estimate
-$0.39
Actual
-$0.52
Surprise
-30.72%
Varex Imaging Corporation Common Stock
Report Date
May 07, 2026 For Q2 26
Estimate
$0.21
Actual
$0.21
Surprise
-1.82%
Accendra Health, Inc.
Report Date
May 11, 2026 For Q1 26
Estimate
-$0.10
Actual
-$0.04
Surprise
+60.90%
InfuSystem Holdings, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.03
Actual
$0.05
Surprise
+46.63%
Apyx Medical Corporation Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.10
Actual
-$0.05
Surprise
+53.75%
Exagen Inc. Common Stock
Report Date
May 11, 2026 For Q1 26
Estimate
-$0.23
Actual
-$0.17
Surprise
+27.87%
Lantheus Holdings, Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.26
Actual
$1.46
Surprise
+15.85%
ICU Medical Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.78
Actual
$1.97
Surprise
+10.26%
Haemonetics Corporation
Report Date
May 07, 2026 For Q4 26
Estimate
$1.28
Actual
$1.29
Surprise
+0.42%
FAQ
What were Kestra Medical Technologies, Ltd. Common Stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Kestra Medical Technologies, Ltd. Common Stock reported EPS of -$0.61, missing estimates by -0.39%, and revenue of $24.55M, 5.29% above expectations.
How did the market react to Kestra Medical Technologies, Ltd. Common Stock's Q3 2026 earnings?
The stock price moved down -7.38%, changed from $21.14 before the earnings release to $19.58 the day after.
When is Kestra Medical Technologies, Ltd. Common Stock expected to report next?
The next earning report is scheduled for Jul 16, 2026.
What are the forecasts for Kestra Medical Technologies, Ltd. Common Stock's next earnings report?
Based on --
analysts, Kestra Medical Technologies, Ltd. Common Stock is expected to report EPS of -$0.60 and revenue of $27.01M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement